Celanese Corporation (CE)

Celanese Corporation is a materials company focused on the production and sale of engineered polymers and acetyl chain products worldwide. Its operations are organized into two segments, Engineered Materials and Acetyl Chain. The company’s engineered materials portfolio includes products such as liquid crystal polymers, thermoplastic elastomers, polyoxymethylene, nylon and polypropylene compounds, and other specialty materials used across applications in automotive, construction, consumer electronics, medical, energy storage, and telecommunications. In its acetyl chain business, Celanese supplies acetic acid, acetic anhydride, vinyl acetate monomers, and related products used in adhesives, coatings, packaging, textiles, pharmaceuticals, and other industrial applications. Celanese markets its products under a broad range of brands and serves customers directly, through distributors, and via original equipment manufacturers and suppliers. Founded in 1912 and headquartered in Irving, Texas, the company is listed on the New York Stock Exchange under the symbol CE.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Payment Date Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-CE
$66.70
39.4% Upside
Undervalued
$62.22
30.1% Upside
Undervalued
Good
November 10, 2026
0.2%
February 23, 2027
19.3x
1.2x
0.5x
5.251 B
14.985 B
66.9%
90.9%
2.3
-1.1%
260.3%
Valuation • Fair Value

Celanese Corporation (NYSE-CE) Fair Value by Valuation Model

Review the available estimates for Celanese Corporation (NYSE-CE), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$66.70

Estimated upside of 39.4% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$84.74

Discounted cash flow valuation reference.

Ben Graham Formula Value

$27.50

Classic Ben Graham valuation formula reference.

DDM Fair Value

$37.91

Dividend discount model valuation reference.

Comps Fair Value

$58.26

Comparable-company valuation reference.

Analyst Price Target

$62.22

Analysts imply upside of 30.1%.

How to read these valuation models

Use the 7 available valuation references for Celanese Corporation (NYSE-CE) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Celanese Corporation (NYSE-CE)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

9.849 B

Current operating scale indicator.

Revenue Forecast

9.903 B

Forward revenue estimate.

EBITDA

1.812 B

Current operating profitability reference.

EBITDA Forecast

2.124 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Celanese Corporation (NYSE-CE) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Celanese Corporation (NYSE-CE)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.71

No elevated caution signal from this screen.

Altman Z-Score

2.3

Intermediate risk zone.

FCF / Net Income

260.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Celanese Corporation (NYSE-CE). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Celanese Corporation (NYSE-CE)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

February 23, 2027

Days to Earnings

109

Dividend Payment Date

November 10, 2026

Dividend Yield

0.2%

Current income yield reference.

Payout Ratio

-1.1%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Celanese Corporation (NYSE-CE), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Celanese Corporation (NYSE-CE) Stock Forecast & Technical Outlook

Review Celanese Corporation (NYSE-CE) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Celanese Corporation (NYSE-CE) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Celanese Corporation (NYSE-CE) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Celanese Corporation (NYSE-CE) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for Celanese Corporation (NYSE-CE) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Celanese Corporation (NYSE-CE) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Celanese Corporation (NYSE-CE)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Celanese Corporation (NYSE-CE) has a Buy consensus, with 9 buy, 8 hold and 0 sell recommendations in the current data set.

Buy 9
Hold 8
Sell 0
FAQ • Fast Investor Answers

Celanese Corporation (NYSE-CE) Stock FAQ

Data-supported answers about Celanese Corporation (NYSE-CE), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$66.70
Estimated upside 39.4%
Valuation Rating
Undervalued
Estimated upside of 39.4%
Analyst Target
$62.22
Implied upside 30.1%
Financial Health
Good
Current financial-health read

The current fair value estimate for Celanese Corporation (NYSE-CE) is $66.70. This implies an estimated upside of 39.4% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 39.4% versus the current market price.

The available analyst price target for Celanese Corporation (NYSE-CE) is $62.22. The analyst target implies estimated upside of 30.1%.

The current financial health read for Celanese Corporation (NYSE-CE) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Celanese Corporation (NYSE-CE) is February 23, 2027.

Based on the current data, dividend yield is 0.2%, payment date is November 10, 2026.

The current P/E ratio listed for Celanese Corporation (NYSE-CE) is 19.3x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Celanese Corporation is 5.251 B.

The current enterprise value listed for Celanese Corporation is 14.985 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Celanese Corporation is NYSE-CE, and the stock is listed on NYSE.

Celanese Corporation (NYSE-CE) is listed on NYSE.

The current debt-to-total-capital ratio listed for Celanese Corporation is 66.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Celanese Corporation is 90.9%. Free float helps investors understand how much of the share base is available for public trading.